Variant report
Variant | esv3415904 |
---|---|
Chromosome Location | chr9:18134672-18135071 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566112365 | chr9:18134673-18134674 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs139981648 | chr9:18134682-18134683 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs533359149 | chr9:18134695-18134696 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs186076418 | chr9:18134712-18134713 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569722519 | chr9:18134742-18134743 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542973958 | chr9:18134801-18134802 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10963470 | chr9:18134821-18134822 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs190748083 | chr9:18134841-18134842 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542451576 | chr9:18134853-18134854 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs763976 | chr9:18134914-18134915 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs534567978 | chr9:18134921-18134922 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1944742 | chr9:18134954-18134955 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs114798819 | chr9:18135001-18135002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374774389 | chr9:18135003-18135004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72699489 | chr9:18135019-18135020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576436237 | chr9:18135025-18135026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs72699490 | chr9:18135038-18135039 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs956323 | chr9:18135051-18135052 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs151040988 | chr9:18135056-18135057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Ovarian cancer | 19835627 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:18127800-18138400 | Weak transcription | Aorta | Aorta |
2 | chr9:18130000-18135800 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
3 | chr9:18133200-18137200 | Enhancers | Colon Smooth Muscle | Colon |
4 | chr9:18134000-18135000 | Enhancers | Stomach Smooth Muscle | stomach |
5 | chr9:18134200-18135200 | Weak transcription | Rectal Smooth Muscle | rectum |
6 | chr9:18134400-18135000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr9:18134800-18135000 | Enhancers | Sigmoid Colon | Sigmoid Colon |
8 | chr9:18135000-18135600 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
9 | chr9:18135000-18136200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr9:18135000-18136200 | Weak transcription | Stomach Smooth Muscle | stomach |